Skip to main content

Apogee Therapeutics, Inc.

corporate_fare Company Profile

Apogee Therapeutics, Inc.

Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications. The company develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for the treatment of AD, which is in phase 2 clinical trials; and for the treatment of asthma and EoE which is in phase 1 clinical trial. It also develops APG279 that is in preclinical stage for the treatment of AD; APG990, an SQ extended half-life mAb for the treatment of AD; APG333, a human mAb against thymic stromal lymphopoietin for the treatment of asthma and COPD; and APG808, an SQ extended half-life mAb targeting IL-4Ra for the treatment of Type 2 allergic diseases. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed APGE - Latest Insights

APGE
Mar 25, 2026, 4:53 PM EDT
Source: Wiseek News
Importance Score:
9
APGE
Mar 25, 2026, 4:44 PM EDT
Filing Type: 8-K
Importance Score:
8
APGE
Mar 25, 2026, 4:40 PM EDT
Filing Type: 424B5
Importance Score:
8
APGE
Mar 24, 2026, 9:54 PM EDT
Source: Reuters
Importance Score:
8
APGE
Mar 23, 2026, 4:28 PM EDT
Filing Type: 424B5
Importance Score:
8
APGE
Mar 23, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
8
APGE
Mar 23, 2026, 6:36 AM EDT
Filing Type: 8-K
Importance Score:
9
APGE
Mar 23, 2026, 6:30 AM EDT
Source: GlobeNewswire
Importance Score:
9
APGE
Mar 02, 2026, 7:25 AM EST
Source: Unknown
Importance Score:
7
APGE
Mar 02, 2026, 7:20 AM EST
Filing Type: 10-K
Importance Score:
9
APGE
Mar 02, 2026, 7:15 AM EST
Filing Type: 8-K
Importance Score:
8
APGE
Feb 11, 2026, 10:42 AM EST
Filing Type: 144
Importance Score:
7
APGE
Jan 22, 2026, 8:07 PM EST
Filing Type: 4
Importance Score:
8
APGE
Jan 22, 2026, 8:03 PM EST
Filing Type: 144
Importance Score:
9
APGE
Jan 22, 2026, 8:00 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
9
APGE
Jan 06, 2026, 7:02 AM EST
Filing Type: 8-K
Importance Score:
9